200 related articles for article (PubMed ID: 28059676)
1. Struggles within Japan's national HPV vaccination: A proposal for future strategy.
Tanaka Y; Ueda Y; Kimura T
Hum Vaccin Immunother; 2017 May; 13(5):1167-1168. PubMed ID: 28059676
[No Abstract] [Full Text] [Related]
2. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
[TBL] [Abstract][Full Text] [Related]
3. HPV vaccination in Japan: what is happening in Japan?
Ikeda S; Ueda Y; Yagi A; Matsuzaki S; Kobayashi E; Kimura T; Miyagi E; Sekine M; Enomoto T; Kudoh K
Expert Rev Vaccines; 2019 Apr; 18(4):323-325. PubMed ID: 30768373
[No Abstract] [Full Text] [Related]
4. Human papillomavirus vaccine introduction--the first five years.
Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
[TBL] [Abstract][Full Text] [Related]
5. Safety of HPV vaccines in the age of nonavalent vaccination.
Quattrone F; Canale A; Filippetti E; Tulipani A; Porretta A; Lopalco PL
Minerva Pediatr; 2018 Feb; 70(1):59-66. PubMed ID: 29363293
[TBL] [Abstract][Full Text] [Related]
6. HPV vaccine uptake in a school-located vaccination program.
Middleman AB; Won T; Auslander B; Misra S; Short M
Hum Vaccin Immunother; 2016 Nov; 12(11):2872-2874. PubMed ID: 27548752
[TBL] [Abstract][Full Text] [Related]
7. The controversy on HPV vaccination in Japan: Criticism of the ethical validity of the arguments for the suspension of the proactive recommendation.
Okita T; Enzo A; Kadooka Y; Tanaka M; Asai A
Health Policy; 2020 Feb; 124(2):199-204. PubMed ID: 31924344
[TBL] [Abstract][Full Text] [Related]
8. A behavioral economics approach to the failed HPV vaccination program in Japan.
Yagi A; Ueda Y; Kimura T
Vaccine; 2017 Dec; 35(50):6931-6933. PubMed ID: 29150210
[No Abstract] [Full Text] [Related]
9. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
Poljak M
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
[TBL] [Abstract][Full Text] [Related]
10. Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan.
Yuji K; Nakada H
Hum Vaccin Immunother; 2016 May; 12(5):1321-4. PubMed ID: 26513303
[TBL] [Abstract][Full Text] [Related]
11. Promoting the immunization neighborhood: Benefits and challenges of pharmacies as additional locations for HPV vaccination.
Rothholz M; Tan LL
Hum Vaccin Immunother; 2016 Jun; 12(6):1646-8. PubMed ID: 27191364
[No Abstract] [Full Text] [Related]
12. History repeats itself in Japan: Failure to learn from rubella epidemic leads to failure to provide the HPV vaccine.
Tanaka Y; Ueda Y; Yoshino K; Kimura T
Hum Vaccin Immunother; 2017 Aug; 13(8):1859-1860. PubMed ID: 28604161
[TBL] [Abstract][Full Text] [Related]
13. Challenge to improve Japan's deplorable HPV vaccination rate by local government actions.
Miyoshi A; Ueda Y; Yagi A; Kimura T; Kobayashi E; Tasaka K; Todo A; Matsunami K; Matsuoka T; Kimura T
J Obstet Gynaecol Res; 2022 May; 48(5):1233-1239. PubMed ID: 35274421
[TBL] [Abstract][Full Text] [Related]
14. The Expanded Impact of Human Papillomavirus Vaccine.
Pahud BA; Ault KA
Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
[TBL] [Abstract][Full Text] [Related]
15. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.
Ueda Y; Yagi A; Abe H; Nakagawa S; Minekawa R; Kuroki H; Miwa A; Kimura T
Sci Rep; 2020 Sep; 10(1):16091. PubMed ID: 32999408
[TBL] [Abstract][Full Text] [Related]
16. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
[TBL] [Abstract][Full Text] [Related]
17. Free school-based vaccination with HPV vaccine in a Japanese city.
Fujiwara H; Suzuki M; Yoshinari T; Shiiya K
Vaccine; 2011 Sep; 29(38):6441-2. PubMed ID: 21704106
[No Abstract] [Full Text] [Related]
18. Update on vaccination clinical trials for HPV-related disease.
Erickson BK; Landers EE; Huh WK
Clin Ther; 2014 Jan; 36(1):8-16. PubMed ID: 24417781
[TBL] [Abstract][Full Text] [Related]
19. Understanding human papillomavirus vaccine uptake.
Fisher WA
Vaccine; 2012 Nov; 30 Suppl 5():F149-56. PubMed ID: 23199958
[TBL] [Abstract][Full Text] [Related]
20. HPV vaccines: what remains to be done? Interview by Lauren Constable.
Zur Hausen H
Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
